Cite

HARVARD Citation

    Saad, F. et al. (n.d.). 834PInterim results of a phase Ib study of niraparib plus androgen receptor-targeted therapy in men with metastatic castration-resistant prostate cancer. Annals of oncology. p. . [Online]. 
  
Back to record